Zymeworks Analyst Price Targets - Benzinga

Zymeworks Inc

ZYMENASDAQ

Trade with Public

Trade with Public

$26.91

1.375.36%

Ult. Agg.: Oct 20, 5:00 PM

$26.91

1.375.36%

Panoramica Notizie Previsioni utili EventiObiettivi di prezzoDati finanziari Sentiment Azionariato Confronta Opzioni Rapporto azionario

Zymeworks Analyst Price Targets - Benzinga

Zymeworks Analyst Price Targets

Wall Street analyst price targets and consensus rating for Zymeworks (ZYME).

Price Target Range — 11 Quarters

Analyst Consensus — 13 Analysts

1S.Buy

12Buy

Consensus RatingBuy# Analysts13Avg. Consensus PT$40Upside to Avg. PT+46.9%

Rating Trend — Last 9 Months

Recent Analyst Actions

Visualizza tutte le valutazioni →

Date	Firm	Analyst	Action	Rating Change	Price Target
Oct 7, 2026	Truist Securities	Gregory Renza	PT Raise	Buy	$32→$34
Sep 29, 2026	Citigroup	Yigal Nochomovitz	PT Raise	Buy	$38→$39
Sep 17, 2026	Wolfe Research	Kalpit Patel	Initiate	Outperform	—
Sep 3, 2026	JP Morgan	Brian Cheng	PT Raise	Overweight	$31→$33
Aug 26, 2026	Citigroup	Yigal Nochomovitz	PT Raise	Buy	$37→$38
Aug 26, 2026	Citizens	Reni J. Benjamin	Maintained	Market Outperform	$32
Aug 26, 2026	HC Wainwright & Co.	Robert Burns	PT Raise	Buy	$51→$55
Aug 10, 2026	B. Riley Securities	Mayank Mamtani	PT Raise	Buy	$40→$44
Aug 7, 2026	Wells Fargo	Eva Fortea Verdejo	PT Raise	Overweight	$37→$40
Aug 7, 2026	Truist Securities	Gregory Renza	PT Raise	Buy	$31→$32
Aug 5, 2026	HC Wainwright & Co.	Robert Burns	PT Raise	Buy	$46→$51
Jul 7, 2026	Truist Securities	Gregory Renza	PT Raise	Buy	$28→$31
Jun 30, 2026	Wells Fargo	Eva Fortea Verdejo	PT Raise	Overweight	$34→$37
Jun 3, 2026	HC Wainwright & Co.	Robert Burns	Maintained	Buy	$46
May 8, 2026	Wells Fargo	Eva Fortea Verdejo	PT Raise	Overweight	$33→$34
Mar 9, 2026	Evercore ISI Group	Jonathan Miller	PT Raise	Outperform	$33→$48
Mar 6, 2026	HC Wainwright & Co.	Robert Burns	PT Raise	Buy	$32→$46
Mar 3, 2026	Stifel	Stephen Willey	PT Raise	Buy	$40→$47
Mar 3, 2026	Leerink Partners	Andrew Berens	PT Raise	Outperform	$52→$58
Dec 17, 2025	Truist Securities	Asthika Goonewardene	Initiate	Buy	$40

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Truist Securities Maintains Buy on Zymeworks, Raises Price Target to $34

Truist Securities analyst Gregory Renza maintains Zymeworks (NASDAQ:ZYME) with a Buy and raises the price target from $32 to $34.

Benzinga Newsdesk

PRO
Citigroup Maintains Buy on Zymeworks, Raises Price Target to $39

Citigroup analyst Yigal Nochomovitz maintains Zymeworks (NASDAQ:ZYME) with a Buy and raises the price target from $38 to $39.

Benzinga Newsdesk

PRO
Wolfe Research Initiates Coverage On Zymeworks with Outperform Rating

Wolfe Research analyst Kalpit Patel initiates coverage on Zymeworks (NASDAQ:ZYME) with a Outperform rating.

Benzinga Newsdesk

PRO
JP Morgan Maintains Overweight on Zymeworks, Raises Price Target to $33

JP Morgan analyst Brian Cheng maintains Zymeworks (NASDAQ:ZYME) with a Overweight and raises the price target from $31 to $33.

Benzinga Newsdesk

PRO
Citigroup Maintains Buy on Zymeworks, Raises Price Target to $38

Citigroup analyst Yigal Nochomovitz maintains Zymeworks (NASDAQ:ZYME) with a Buy and raises the price target from $37 to $38.

Benzinga Newsdesk

MongoDB To Rally Around 14%? Here Are 10 Top Analyst Forecasts For Wednesday

Top analysts changed outlook on top names: Piper raised $INTU price target, Ascendiant raised $QUBT target, BTIG cut $DKS target, HC raised $ZYME target, Needham increased $JAZZ target, Bernstein cut $MSTR target, Barclays raised $MDB target, UBS raised $SMTC target.

Avi Kapoor